Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
102453 trials found · Page 176 of 5123
-
Could a diabetes drug curb alcohol cravings and save livers?
Disease control Recruiting nowBackground: People with alcohol use disorder (AUD) often develop metabolic alcohol-associated liver disease (MetALD). MetALD is a term for the heart, liver, obesity, and other issues that can accompany AUD. MetALD can be fatal. An approved weight management drug (Tirzepatide) ma…
Phase: PHASE2 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
New AI tool could spot sepsis in kids before It's too late
Diagnosis Not yet recruitingThe overall objective of this proposed research is the derivation of a biomarker-enhanced artificial intelligence (AI)-based pediatric sepsis screening tool (PSCT) (software) that can be used in combination with the hospital's electronic health record (EHR) system to monitor and …
Sponsor: Computer Technology Associates, Inc. • Aim: Diagnosis
Last updated Jun 05, 2026 12:06 UTC
-
10-Year showdown: stents or pills for clogged arteries?
Disease control Not yet recruitingThe goal of this clinical trial is to compare long term efficacy of drug-eluting stent implantation compare to optimal medical treatment in patient with chronic total occlusion in a very long-term follow-up (minimum 10 years) period.
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New pill could ease lupus skin flares in major trial
Disease control Recruiting nowThe purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 …
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 27, 2026 11:51 UTC
-
New drug combo aims to boost radiation for early lung cancer
Disease control Not yet recruitingMajor objectives to evaluate the efficacy and safety of lparomlimab and Tuvonralimab Injection ((QL1706, an Anti-PD-1/CTLA-4 Combined Antibody)) combined with SBRT in patients with early-stage non-small cell lung cancer.
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 01, 2026 17:55 UTC
-
New score could guide ovarian cancer surgery timing
Disease control Not yet recruitingA prospective, international, multi-center, interventional trial of advanced epithelial ovarian cancer patients offered three cycles of neoadjuvant chemotherapy (NACT) and triaged with KELIM score. Patients with favorable score will undergo interval debulking surgery (IDS) follow…
Phase: NA • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jun 10, 2026 18:37 UTC
-
New hope for elderly lymphoma patients: triple-drug combo targets aggressive cancer
Disease control Not yet recruitingThis is a single-arm, prospective, multicenter, open-label phase Ib/II study to evaluate the safety and efficacy of polatuzumab vedotin in combination with rituximab and chidamide in previously untreated elderly patients with MYC/BCL2 double-expressor diffuse large B-cell lymphom…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC
-
New drug aims to cut blood transfusions for bone marrow disease patients
Disease control Recruiting nowThe main aim of this study is to assess how elritercept works in lowering the need for RBC (red blood cell) transfusions and how safe elritercept is when compared with epoetin alfa. Other aims are to learn if elritercept improves tiredness as reported by participants without need…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC
-
Spinal injury breakthrough: brain zaps may restore grip
Symptom relief Recruiting nowThe goal of this study is to restore the activities of late descending signals with a noninvasive stimulation approach in combination with hand motor training to improve hand function in persons with cervical SCI. The main question it aims to answer is if the inputs to late desce…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jun 10, 2026 13:27 UTC
-
Smart insulin systems for kids: could early use change diabetes care?
Disease control Not yet recruitingThe purpose of this study is to investigate the effect of early initiated automated insulin de-livery (AID) treatment in type diabetes in children aged 7-16 years to glycemic control, diabe-tes distress of patients and caregivers, long-term micro- and macrovascular complications …
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC
-
New vaccine aims to wipe out HPV and reverse precancerous cervical lesions
Disease control Recruiting nowThe purpose of this Phase 2 study is to compare the effects of administering the PVX4 combination device biologic product (pBI-4 DNA vaccine via electroporation-mediated intramuscular delivery with the TriGrid™ Delivery System) in patients with biopsy-confirmed, human papilloma v…
Phase: PHASE2 • Sponsor: PapiVax Biotech, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
New study seeks best Post-Surgery care for advanced oral cancer
Disease control Not yet recruitingNeoadjuvant immunochemotherapy (NAIC) has demonstrated promising pathological and survival outcomes in patients with resectable locally advanced oral and oropharyngeal squamous cell carcinoma (LA-OSCC/OPSCC). However, the optimal postoperative management strategy following NAIC a…
Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
VR goggles could spot hidden brain injuries in minutes
Diagnosis Recruiting nowAccurate and non-invasive methods for objectively identifying and monitoring head injuries (such as a concussion) are still an unmet need. It is known that pupil constriction in response to light stimuli can reflect changes in neural activity in the brain and is associated with s…
Sponsor: Sheba Medical Center • Aim: Diagnosis
Last updated Jun 01, 2026 18:06 UTC
-
Promising new treatment for rare blood vessel disease enters human trials
Disease control Not yet recruitingTakayasu's arteritis (TAK) is a large vessel vasculitis preferentially affecting the aorta and its main branches, leading to wall vessels thickening, fibrosis, stenosis, and occlusion. Patients with TAK have a high morbidity rate, 50% will relapse and experience a vascular compli…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
Ancient herb meets modern medicine in quest to prevent liver cancer
Disease control Not yet recruitingThis study aims to establish a prospective, multicenter, randomized, double-blind, placebo-controlled parallel-group clinical trial cohort. The cohort will include high-risk populations for hepatitis B cirrhosis-related hepatocellular carcinoma (HCC) from multiple centers nationw…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
New combo therapy aims to shrink hard-to-treat colorectal tumors
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether a high- and low-dose radiotherapy regimen followed by anti-angiogenic TKI and anti-PD-1 antibody therapy works to treat advanced metastatic colorectal cancer. It will also evaluate long-term survival outcomes and explore potenti…
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
New hope for elderly blood cancer patients: tailored transplant regimen aims to boost survival
Disease control Recruiting nowAcute myeloid leukemia (AML) is one of the most common hematologic malignancies. With increasing life expectancy and the aging of society, the incidence of AML in the elderly population is rising. The prognosis of elderly AML patients is significantly worse than that of younger p…
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 29, 2026 14:20 UTC
-
New hope for esophageal cancer patients when first treatment fails
Disease control Not yet recruitingThe goal of this clinical trial is Iparomlimab and tuvonralimab (QL1706) combined with chemoradiotherapy in the treatment of locally advanced esophageal cancer after failed neoadjuvant chemoimmunotherapy. The main question it aims to answer is: Can it bring survival benefits and …
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New keyhole breast surgery could offer better looks and same safety
Symptom relief Not yet recruitingThis study is a multicenter, open-label, randomized controlled trial. The study aims to evaluate differences in operative efficiency (e.g., operative time), economic effect, surgical safety (e.g., surgical complication rates), postoperative aesthetics (e.g., BREAST-Q scores, Harr…
Phase: NA • Sponsor: Du Zhenggui • Aim: Symptom relief
Last updated May 26, 2026 12:10 UTC
-
New combo aims to stop leukemia from coming back
Disease control ENROLLING_BY_INVITATIONThis study intends to use a randomized controlled design to compare the MRD-negativw rate and related efficacy and safety of venetoclax combined with intermediate-dose cytarabine (IDAC) versus IDAC in the consolidation treatment of patients with AML after remission, providing hig…
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC